Otonomy announces FDA approval of Otiprio for the treatment of pediatric patients undergoing tympanostomy tube placement surgery

11 December 2015 - Otiprio is a single-dose, physician-administered antibacterial and the first product approved by the FDA for this indication.

For more details, go to: http://investors.otonomy.com/phoenix.zhtml?c=234082&p=RssLanding&cat=news&id=2121968

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , US